Trial to evaluate neurocognitive functions, neuropsychiatric changes and activities of daily living among HIV infected patients in the cohort HIV-NAT 006 study

Project no.: HIV-NAT 166

This is an observational study among treatment naive or experienced HIV-infected adults who has been deferred, interrupted or initiated the first line antiretroviral regimens and currently on antiretroviral therapy using self-assessed questionnaires about neuropsychiatric changes and daily activities and brief assessment of neurological performance with International HIV dementia scale (IHDS) and Montreal Cognitive Assessment (MoCA). Other tests such as Trial making, EIWA digit symbol task, Grooved pegboard test and block design will also be done.

This study will describe the rates of neurocognitive changes among HIV-infected patients in the Cohort 006 study and determine factors related to neurocognitive changes among HIV-infected patients.